Vipul Jairath

7PUBLICATIONS
15CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Major global burdens of diseaseImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 02, 2023
Targeting IL-23 for IBD: Rationale and Progress to Date.

Sudheer K Vuyyuru, Lisa M Shackelton, Jurij Hanzel

|Aug 28, 2021
Correction to: Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease.

Jurij Hanzel, Christopher Ma, Niels Vande Casteele

|Jan 05, 2021
Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease.

Jurij Hanzel, Christopher Ma, Niels Vande Casteele

|Oct 26, 2020
Clinical Trials of IL-12/IL-23 Inhibitors in Inflammatory Bowel Disease.

Ahmed Almradi, Jurij Hanzel, Rocio Sedano

|Jul 19, 2019
Innovations in Oral Therapies for Inflammatory Bowel Disease.

Christopher Ma, Robert Battat, Parambir S Dulai

|Jul 31, 2018
Investigational drugs in phase I and phase II clinical trials targeting interleukin 23 (IL23) for the treatment of Crohn's disease.

Christopher Ma, Vipul Jairath, Reena Khanna

Pageof 2